Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Reata offers update on ongoing CARDINAL study of bardoxolone in Alport syndrome

April 12, 2018

Recordati acquires rights to Cystagon

April 9, 2018

Topline results from phase II study of fostamatinib in IgA nephropathy

April 4, 2018

Retrophin initiates pivotal phase III DUPLEX study of sparsentan

April 4, 2018

Urovant initiates phase III trial of vibegron in overactive bladder

March 29, 2018

Vifor Pharma grants Zeria license to develop and market Veltassa in Japan

March 29, 2018

Bardoxolone methyl granted Sakigake designation in Japan

March 28, 2018

Vitaros end-of-review meeting scheduled by FDA

March 27, 2018

Phase III efficacy and safety data reported for vibegron in overactive bladder

March 27, 2018

Lokelma receives E.U. approval for hyperkalemia

March 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...